Evaluation of the imunogenicity of one recombinant protein for the prevention of acute pneumonia in alpacas (Vicugna pacos)

Authors

  • Gerald Moreno-Morales Universidad Nacional Mayor de San Marcos, Facultad de Medicina Veterinaria, Unidad de Biología y Genética Molecular. Lima, Peru
  • Jorge Maximiliano G. Universidad Nacional Mayor de San Marcos, Facultad de Medicina Veterinaria, Unidad de Biología y Genética Molecular. Lima, Peru
  • Juan Siuce M. Universidad Nacional Mayor de San Marcos, Facultad de Medicina Veterinaria, Unidad de Biología y Genética Molecular. Lima, Peru
  • Ana Chero O. Universidad Nacional Mayor de San Marcos, Facultad de Medicina Veterinaria, Unidad de Biología y Genética Molecular. Lima, Peru
  • Guido Medina S. Centro de Investigación y Producción La Raya, Universidad Nacional del Altiplano, Puno
  • Luis Luna E. Unidad de Biología y Genética Molecular, Facultad de Medicina Veterinaria, Universidad Nacional Mayor de San Marcos, Lima
  • Raúl Rosadio A. Universidad Nacional Mayor de San Marcos, Facultad de Medicina Veterinaria, Unidad de Biología y Genética Molecular. Lima, Peru
  • Lenin Maturrano H. Universidad Nacional Mayor de San Marcos, Facultad de Medicina Veterinaria, Unidad de Biología y Genética Molecular. Lima, Peru https://orcid.org/0000-0001-8819-7335

DOI:

https://doi.org/10.15381/rivep.v32i4.20924

Keywords:

Pasteurella multocida, vaccine, P6-like, Omp16, alpaca, indirect ELISA

Abstract

The aim of this study was to evaluate the in vivo immunogenic capacity of a recombinant outer membrane protein of Pasteurella multocida called P6-like (rP6-like). The field trial was carried out in an alpaca production unit in Puno, Peru, and the processing of the samples was done in the Faculty of Veterinary Medicine of San Marcos University in Lima. Four groups of 5 animals were formed, and they were inoculated according to group with a) normal saline solution, b) bacterin, c) rP6-like, d) combination of bacterin + rP6-like. Blood samples were collected on days 0, 5, 7, 9, 12 and 15 post-inoculation. Single-point indirect ELISA tests were designed for the relative quantification of specific anti-rP6-like antibodies and for total anti-total P. multocida protein antibodies. The group inoculated with rP6-like showed significant elevation of antibodies from day 7 (p<0.05) until day 15 post-inoculation. The other biological products did not show significant elevation during the studied period. The study showed the immunogenic capacity of rP6- like, which allows to continue with future efficacy studies.

Downloads

Download data is not yet available.

Downloads

Published

2021-08-24

Issue

Section

Artículos Primarios

How to Cite

Moreno-Morales, G., Maximiliano G., J., Siuce M., J., Chero O., A., Medina S., G., Luna E., L., Rosadio A., R., & Maturrano H., L. (2021). Evaluation of the imunogenicity of one recombinant protein for the prevention of acute pneumonia in alpacas (Vicugna pacos). Revista De Investigaciones Veterinarias Del Perú, 32(4), e20924. https://doi.org/10.15381/rivep.v32i4.20924